Clinical Outcomes of Bilateral Stent-in-Stent Placement Using Self-Expandable Metallic Stent for High-Grade Malignant Hilar Biliary Obstruction.
10.3349/ymj.2018.59.7.827
- Author:
Ja Yoon HEO
1
;
Hee Seung LEE
;
Jun Hyuk SON
;
Sang Hyub LEE
;
Seungmin BANG
Author Information
1. Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea. bang7028@yuhs.ac
- Publication Type:Original Article
- Keywords:
Malignant hilar biliary obstruction;
stent-in-stent;
self-expandable metallic stent;
stent patency
- MeSH:
Bile Ducts;
Bilirubin;
Decompression;
Drainage;
Follow-Up Studies;
Humans;
Jaundice, Obstructive;
Methods;
Multivariate Analysis;
Proportional Hazards Models;
Risk Factors;
Stents*
- From:Yonsei Medical Journal
2018;59(7):827-833
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Endoscopic bile duct decompression using bilateral self-expandable metallic stents (SEMSs) deployed via a stent-in-stent (SIS) method is considered a preferred procedure for malignant hilar biliary obstruction (MHBO). However, occlusion thereof occurs frequently. Here, we investigated stent patency duration and risk factors related to stent obstruction with bilateral SIS placement for MHBO at two large centers. MATERIALS AND METHODS: The present study reviewed data on patients with MHBO who underwent endoscopic biliary drainage using the SIS method. Clinical outcomes, including stent patency duration and patient overall survival, were analyzed. Factors associated with stent patency were evaluated using Cox proportional hazards models. RESULTS: Seventy patients with MHBO underwent endoscopic biliary drainage using the SIS method. Median age was 68 years old, and median follow-up duration was 140 days (interquartile range, 57–329). The proportion of high-grade MHBOs (Bismuth type IV) was 57.1%. Median stent patency duration with the SIS method was 108 days according to Kaplan-Meier curves. Median patient survival analyzed by the Kaplan-Meier method was 181 days. Multivariate analysis indicated that higher baseline bilirubin (> 6.1 mg/dL) as an independent risk factor related to stent patency (p < 0.05). CONCLUSION: In endoscopic biliary decompression using SEMS placed with the SIS method, obstructive jaundice was a risk factor for stent patency. The SIS method for high-grade MHBO showed short stent patency.
